News
The annual Alzheimer's disease drug development pipeline report is led by Dr. Jeffrey Cummings, a renowned Alzheimer's clinician-scientist. The report reviews the status and associated trends ...
People who follow a MIND diet, even if started later in life, were significantly less likely to develop Alzheimer's disease or related forms of dementia, according to new research.
Hope is on the horizon as a new review indicates a growing number of potential treatments for Alzheimer’s disease.. The review, spearheaded by a University of Nevada expert and featured in the ...
Between 1995 and 2021 private money spent on Alzheimer’s research came to $42.5bn, but more than 140 trials failed to yield a single drug capable of slowing the disease. Yet the tide may be turning.
A new era in Alzheimer disease detection may be on the horizon with the development of a novel blood test. 1,2 This diagnostic tool, known as Penta-Plex Alzheimer’s Disease Capture Sandwich ...
The Alzheimer’s drug pipeline is healthier than you might think There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 ...
The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer’s disease. It’s got quite the name. The Lumipulse G pTau217 ...
Creatine supplements demonstrated a hint of promise for people with Alzheimer's disease in the pilot CABA trial. In the single-arm study of 20 Alzheimer's patients who received 20 g/day of ...
Research findings suggest that a new blood test for Alzheimer’s disease has shown promise in accurately identifying people with early symptoms. Experts from the Mayo Clinic in the United States ...
A new blood test for Alzheimer's disease has shown promise in accurately identifying people with early symptoms, according to new research from the US Express. Home of the Daily and Sunday Express.
A new way of thinking about Alzheimer's disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer's and other neurodegenerative diseases, including ...
Scientists identify immune molecule STING as key driver of Alzheimer's brain damage - Medical Xpress
A new way of thinking about Alzheimer's disease has yielded a discovery that could be the key to stopping the cognitive decline seen in Alzheimer's and other neurodegenerative diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results